2 FTSE 100 dividend stocks I’d buy and hold for the next 10 years

These two FTSE 100 (INDEXFTSE:UKX) shares could offer income investing potential in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the FTSE 100 having a dividend yield of around 4.3%, there are numerous income investing opportunities available to investors at the present time.

In the long run, many of those companies could offer improving financial performance that boosts their share prices. And, since their valuations continue to be low in many cases, now could be the right time to buy them.

Here are two prime examples of dividend stocks that could outperform the FTSE 100 in the next decade.

GSK

Healthcare companies such as GSK (LSE: GSK) could experience strong earnings growth over the next 10 years. Demand for a range of healthcare services and drugs is likely to increase as the world’s population grows in size and also continues to see its average age rise.

GSK’s recent updates have shown that it is making progress in implementing its current strategy. This includes a joint venture within its consumer health brands portfolio, as well as M&A activity within its pharma sector. These changes could catalyse its financial performance and increase its appeal among investors.

The company’s dividend has been frozen on a per share basis over recent years. This has been a positive move in terms of the overall financial health of the business, since it now means that dividends are covered 1.5 times by net profit. There may now be scope for shareholder payouts to increase at a brisk pace, while a dividend yield of 4.5% is competitive compared to other FTSE 100 stocks.

With GSK trading on a price-to-earnings (P/E) ratio of 15, it seems to offer good value for money given its long-term prospects. As such, now could be the right time to buy a slice of it.

Berkeley

Another FTSE 100 share that could be worth buying and holding for the next decade is Berkeley (LSE: BKG). The prime housebuilder, which focuses on the London market, has experienced a challenging set of trading conditions in recent years.

Planning difficulties and lower demand following the EU referendum have contributed to weaker levels of profitability. However, the company is placed favourably to benefit from an improvement in the London housing market, where it has a large market share compared to many of its sector peers.

Encouragingly, Berkeley has a strong balance sheet and an ability to focus on long-term projects. This strategy is performing relatively well according to its recent updates, with the company on track to meet its medium-term financial guidance.

With the stock forecast to pay a dividend yield of 3.5% in the current year and 4.1% next year, it continues to offer sound income opportunities. And, with the London property market having the potential to gain ground as political risk subsides, now could be the right time to buy a slice of the stock and hold it for the long run.

Peter Stephens owns shares of Berkeley Group Holdings and GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Two elderly people relaxing in the summer sunshine Box Hill near Dorking Surrey England
Investing Articles

Forget the FTSE 100 and come back after summer? Here’s my plan!

With the FTSE 100 moving around in a volatile way, should our writer just forget all about it for a…

Read more »

Young female hand showing five fingers.
Investing Articles

£20,000 invested in a Stocks and Shares ISA 5 years ago could now be worth…

The last five years have been something of a roller coaster for the markets. How would £20k in a Stocks…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Stock market correction: a once-in-a-decade chance to build big passive income?

Ben McPoland takes a closer look at a high-yield passive income stock from the FTSE 250 that investors have been…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

In volatile markets, could National Grid dividends be a safe haven?

National Grid offers a dividend yield well above the FTSE 100 and aims to keep growing its payout per share.…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Down 25%, are Barclays shares simply too cheap to ignore?

Barclays shares have given up a chunk of their recent gains since the Middle East powder keg ignited. Should investors…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

How much would someone need in an ISA to target a £1,000 monthly second income?

Christopher Ruane explains how someone could use an empty Stocks and Shares ISA to target a four-figure monthly second income…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Are investors taking a big gamble chasing Rolls-Royce shares higher and higher?

With Rolls-Royce shares having fallen back from their peak, the temptation to see this as a buying opportunity must be…

Read more »

Cargo containers with European Union and British flags reflecting Brexit and restrictions in export and import
Investing Articles

Down 70%, is Fevertree Drinks a share to consider buying at 815p?

Fevertree reported its 2025 earnings today and the investors liked what they saw. So is this a share to consider…

Read more »